Clinical Trial

PSTC100 Study in Healthy Adult Subjects

Name: PSTC100 Study in Healthy Adult Subjects — clinical trial record (NCT07752472)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic (PD) characteristics of PSTC100 in healthy adult subjects.

Trial Details

NCT Number	NCT07752472
Lead Sponsor	Prospect Therapeutics (Nanjing) Limited
Conditions	Healthy Adult Subjects
Enrollment	70 participants
Start Date	2026-09-07
Primary Completion	2027-07-12 (estimated)
Study Completion	2027-10-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-07